Welcome to ISMAP's - International Students Medical Association in Pilsen - website. We are an association made by students from the Faculty of Medicine (in Pilsen) of Charles University in Prague, regardless of their nationality. We were founded on May 2007, after dealing with all the legal aspects related with the making of an association. Feel free to find more about us on this website!
For all the freshmen. Get registered as soon as possible.
Welcome Freshmen!!
Support children suffering from cancer
2 nice flats with garden and winter pool.
Scientific Sub-Committee is pleased to announce you the new updates to our web! Check out Tick-Borne Encephalitis and an official blood parameters table
29 Jul 2010
Etubics Corporation, a biopharmaceutical company developing "next generation" vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen (CEA)-expressing cancers such as colorectal cance...
29 Jul 2010
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next step in the evolution of minimally invasive surgery. Removing the prostate is a common treatment ...
29 Jul 2010
The National Comprehensive Cancer Network (NCCN) has been awarded two individual $2 million grants from GlaxoSmithKline (GSK) to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the trea...
29 Jul 2010
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer. The award is part of the latest round of grant disbursements from the Cancer Prevention and ...
29 Jul 2010
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) f...
29 Jul 2010
Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer a...
29 Jul 2010
Researchers at the University of California, San Francisco propose that treatments used on liver cancers beyond the established Milan criteria for liver transplantation may be appropriate for all patients with hepatocellular carcinoma (HCC) who are listed for transplantation...
29 Jul 2010
Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 800 Scottish women and 9,000 UK women each year. The team are the first to identify a gene's key role in causing th...
29 Jul 2010
Organ transplant patients who develop cancer may be helped by a treatment that uses blood cells to attack their tumour. University of Edinburgh researchers have generated a bank of white blood cells from healthy blood donors to treat patients with a blood cancer called post transplant lymphoproli...
29 Jul 2010
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the Natio...
29 Jul 2010
Synta Pharmaceuticals Corp...
29 Jul 2010
In Germany, several national health campaigns promote cancer screening by announcing that only one in five German men gets screened. This is supposed to motivate men to have an examination...